Edition:
United States

Alchemia Ltd (ACL.AX)

ACL.AX on Australia Stock Exchange

0.01AUD
8 Dec 2016
Change (% chg)

-- (--)
Prev Close
$0.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
184,632
52-wk High
$0.02
52-wk Low
$0.01

ACL.AX

Chart for ACL.AX

About

Alchemia Limited is a biotechnology company. The Company is engaged in the sale of its around the world intellectual property rights to Fondaparinum sodium, a generic anti-coagulant drug to Dr Reddy's Laboratories; closure of clinical trial activities, and review of new opportunities. The Company's segments include Fondaparinux... (more)
No analyst recommendations are available for ACL.AX.

Overall

Beta: -0.08
Market Cap(Mil.): $2.92
Shares Outstanding(Mil.): 324.72
Dividend: 0.09
Yield (%): --

Financials

  ACL.AX Industry Sector
P/E (TTM): 0.14 41.98 30.40
EPS (TTM): 0.07 -- --
ROI: 300.79 -0.36 15.24
ROE: 300.81 -0.94 16.58

Earnings vs. Estimates